Speeding innovation for industry
CEA-Leti, in collaboration with CEA's Fundamental Research Division, has developed a new vaccine approach for HIV based on engineered lipid nanoparticles that deliver p24 –- a viral protein that is key to an HIV vaccine –- and optimize the CpG adjuvant's effect.
For the eighth consecutive year, the CEA has been ranked in the Top 100 Global Innovators thanks to its proactive intellectual property policy. It is the only French research body to appear in the Clarivate 2018 list.
Smart Battery for Electric Cars, Bikes, Robots & Smartphones Powers on Even When Cell Fails
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.